SCHEMBL4751122

SCHEMBL4751122

CNC(=[O+]C)N(C)C.F[B-](F)(F)F.F[B-](F)(F)F.F[B-](F)(F)F.F[B-](F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL51352 1.00
SCHEMBL118665 1.00
SCHEMBL19665 0.89
Hydrochloric Acid SCHEMBL5860643 0.87
SCHEMBL1952432 0.85
SCHEMBL5682973 0.82
Methylene Chloride SCHEMBL2347771 0.80
SCHEMBL4962709 0.78
SCHEMBL7339903 0.78
Phosphoric Acid SCHEMBL1936779 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2831264-B1 BACTERIAL IMAGING AGENTS AND METHODS OF USING SAME VISEN MEDICAL INC (US) 2019-07-10 EP disclosed
US-9375493-B2 Bacterial imaging agents and methods of using same VISEN MEDICAL, INC. (US) 2016-06-28 US disclosed
EP-2831264-A1 BACTERIAL IMAGING AGENTS AND METHODS OF USING SAME VisEn Medical, Inc. (US) 2015-02-04 EP disclosed
US-20130309168-A1 BACTERIAL IMAGING AGENTS AND METHODS OF USING SAME VISEN MEDICAL, INC. (US) 2013-11-21 US disclosed
WO-2013148319-A1 BACTERIAL IMAGING AGENTS AND METHODS OF USING SAME VISEN MEDICAL, INC. (US) 2013-10-03 WO disclosed
WO-2008145398-A1 4-ARYLPYRROLE SUBSTITUTED 2-INDOLINE DERIVATIVES ACTIVE AS PROTEIN KINASE INHIBITORS PFIZER ITALIA S.R.L. (IT) 2008-12-04 WO disclosed
US-7355069-B2 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance ASTRAZENECA AB (SE) 2008-04-08 US disclosed
US-20050256198-A1 Ortho-substituted benzoic acid derivatives for the treatmetn of insulin resistance ASTRAZENECA AB (SE) 2005-11-17 US disclosed
EP-1414792-A1 FLUORO LINKERS AND THEIR USE AS LINKERS FOR ENZYME-ACTIVATED DRUG CONJUGATES Pharmacia Italia S.p.A. (IT) 2004-05-06 EP disclosed
WO-2003085031-A1 SWELLABLE, EASILY CROSS-LINKED, ESSENTIALLY LINEAR POLYMERS, AND THE USE OF THE SAME IN SOLID PHASE SYNTHESIS RADEMANN JOERG (DE) 2003-10-16 WO disclosed
EP-1309590-A1 AZAINDOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS ANTITUMOR AGENTS Pharmacia Italia S.p.A. (IT) 2003-05-14 EP disclosed
WO-2003014069-A1 FLUORO LINKERS AND THEIR USE AS LINKERS FOR ENZYME-ACTIVATED DRUG CONJUGATES PHARMACIA ITALIA SPA (IT) 2003-02-20 WO disclosed
WO-2001098299-A1 AZAINDOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA ITALIA S.P.A. (IT) 2001-12-27 WO disclosed